Trucept Stock Performance
| TREP Stock | USD 0.04 0.01 29.86% |
On a scale of 0 to 100, Trucept holds a performance score of 2. The entity has a beta of 0.39, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Trucept's returns are expected to increase less than the market. However, during the bear market, the loss of holding Trucept is expected to be smaller as well. Please check Trucept's downside variance, as well as the relationship between the daily balance of power and period momentum indicator , to make a quick decision on whether Trucept's existing price patterns will revert.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Trucept are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile technical and fundamental indicators, Trucept reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Total Cashflows From Investing Activities | -28 K |
Trucept |
Trucept Relative Risk vs. Return Landscape
If you would invest 5.00 in Trucept on August 29, 2024 and sell it today you would lose (1.50) from holding Trucept or give up 30.0% of portfolio value over 90 days. Trucept is currently generating 0.4627% in daily expected returns and assumes 14.8671% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Trucept, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Trucept Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Trucept's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Trucept, and traders can use it to determine the average amount a Trucept's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0311
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TREP | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 14.87 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.46 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Trucept is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Trucept by adding it to a well-diversified portfolio.
Trucept Fundamentals Growth
Trucept Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Trucept, and Trucept fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Trucept Pink Sheet performance.
| Return On Equity | 0.0036 | |||
| Return On Asset | -0.006 | |||
| Profit Margin | 0 % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 221.15 K | |||
| Shares Outstanding | 50.26 M | |||
| Price To Earning | (0.05) X | |||
| Price To Sales | 0.10 X | |||
| Revenue | 20 M | |||
| EBITDA | (7.28 M) | |||
| Cash And Equivalents | 78.09 K | |||
| Total Debt | 1.13 M | |||
| Book Value Per Share | 0.32 X | |||
| Cash Flow From Operations | 2.44 M | |||
| Earnings Per Share | (0.16) X | |||
| Total Asset | 18.96 M | |||
| Retained Earnings | (21.58 M) | |||
| Current Asset | 4.89 M | |||
| Current Liabilities | 33.22 M | |||
About Trucept Performance
Assessing Trucept's fundamental ratios provides investors with valuable insights into Trucept's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Trucept is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Trucept, Inc., through its subsidiaries, provides business services in the United States. The company was formerly known as Smart-Tek Solutions, Inc. and changed its name to Trucept, Inc. in January 2013. Trucept operates under Staffing Employment Services classification in the United States and is traded on OTC Exchange.Things to note about Trucept performance evaluation
Checking the ongoing alerts about Trucept for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Trucept help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Trucept had very high historical volatility over the last 90 days | |
| Trucept has some characteristics of a very speculative penny stock | |
| Trucept has high likelihood to experience some financial distress in the next 2 years | |
| Trucept currently holds 1.13 M in liabilities. Trucept has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Trucept until it has trouble settling it off, either with new capital or with free cash flow. So, Trucept's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Trucept sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Trucept to invest in growth at high rates of return. When we think about Trucept's use of debt, we should always consider it together with cash and equity. |
- Analyzing Trucept's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Trucept's stock is overvalued or undervalued compared to its peers.
- Examining Trucept's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Trucept's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Trucept's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Trucept's pink sheet. These opinions can provide insight into Trucept's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Trucept Pink Sheet Analysis
When running Trucept's price analysis, check to measure Trucept's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trucept is operating at the current time. Most of Trucept's value examination focuses on studying past and present price action to predict the probability of Trucept's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trucept's price. Additionally, you may evaluate how the addition of Trucept to your portfolios can decrease your overall portfolio volatility.